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Myoﬁbroblastoma  of  the  breast  is  a rare  benign  mesenchymal  tumor.  The  literature  describes  relatively
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few  cases  of  this  type  of  tumor.  We  report  on  a new  case  of myoﬁbroblastoma  in  a  65-year  old  man
successfully  managed  at our  institution.  The  purpose  of  this  case  report  is  to  highlight  characteristics  and
differential  diagnosis  of  this  rare  neoplasm.
© 2011 Surgical Associates Ltd. Elsevier Ltd. Open access under CC BY-NC-ND license.yoﬁbroblastoma
. Introduction
Myoﬁbroblastoma of the breast is an uncommon benign stromal
umor, predominantly occurring in menopausal women and older
en. The clinical presentation is characterized by a mobile, well
eﬁned and solid palpable tumor. Histologically myoﬁbroblastoma
s well demarcated and composed of bipolar spindle cells structured
ollagen bundles. Based on histological, immunohistochemical and
ltrastructural observations, tumor cells have mesenchymal origin
nd show myoﬁbroblastic differentiation. This type of tumor causes
ifferential diagnostic problems by mammography and ultrasonog-
aphy, as it appears in several different variations and for example
an be confused with hamartoma or ﬁbroadenoma.
. Case presentation
A  65-year-old man  was referred to our institution for a
arge lump in the right mammary region. He was an otherwise
ealthy man, although on medications for hypercholesterolemia
nd hypertension. There was no family history of breast cancer.
he lump, which initially appeared as a small and asymptomatic
welling, had slowly enlarged for more than a decade. On exami-
ation, there was a large tumor located underneath the areola and
easuring 13 cm of maximum diameter (Fig. 1). The lesion was
ultilobulated, well-deﬁned and freely mobile with respect to the
nderlying muscular plane, but adherent to the overlying skin. The
umor was clinically considered benign and there was no regional
ymph nodes involvement. Mammography and ultrasonography
howed a smooth well-deﬁned tumor measuring 10 cm × 8 cm
Fig. 2). Ultrasonography also displayed a mixed echogenic gland
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Open access under CC BY-NC-ND liceand adipose tissue. Tru-cut biopsy was suggestive of adenomy-
oepithelioma or pleomorﬁc adenoma. Therefore, the tumor was
completely excised with the overlaying skin and preserving the
nipple (Fig. 3). The post-operative period was  uneventful. Gross
examination revealed a 10-cm, well-demarcated nodular tumor
with reddish brown cut surface and ﬁnely lobulated adipose tissue
in the central area. There was a free resection margin measuring
5–10 mm.
Tumor  tissue blocks were ﬁxated in neutral buffered 10% for-
malin for 48 h. 3–5 m slides were made from parafﬁn embedded
tissue blocks and stained routinely with haematoxylin–eosin (HE).
Immunohistochemistry was performed using DAKO Autostainer
Universal Staining System (Figs. 4 and 5).
Histological examination revealed a well-deﬁned and pseudo-
encapsulated tumor, surrounded by adipose tissue. Tumor was
cellular and vaguely nodular, with mesenchymal appearance,
devoid of breast parenchyma and with abundant “entrapped”
islands of adipose tissue or separate adipocytes. Tumor cells were
bipolar, monomorphic, showing oval nuclei without atypia and
with very scant mitotic activity. Cells were arranged in ill-deﬁned
fascicles, haphazardly intermingled with coarse short bundles
of collagen. There were no areas of necrosis, hemorrhage or
metaplastic changes. Immunohistochemistry revealed a positive
reaction of tumor cells for actin, desmin, vimentin, caldesmon and
CD34, while reaction for S100 and cytokeratin 7/19 was nega-
tive. The proliferative fraction of tumor cells, detected with Ki-67,
was 1–5%. Present ﬁndings were consistent with a diagnosis of
myoﬁbroblastoma.
3. DiscussionMyoﬁbroblastoma was  ﬁrst characterized by Wagortz et al. in
1987, reporting on 16 of such cases.7 This tumor is a rare and
benign mesenchymal lesion, which shares similarities with other
nse.
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aFig. 1. Asymmetry with great palpable mass in the right side.
umors as spindle cell lipoma-like tumor, solitary ﬁbrous tumor,
yoﬁbroblastoma, leiomyoma and benign ﬁbrous histiocytoma.
ll these lesions are classiﬁed as benign spindle cell neoplasms,
hich may  show ﬁbroblastic, myoﬁbroblastic and ﬁbrohistiocytic
spects.2,5,6,10,12,17 Perhaps, they all derive from the same type of a
Fig. 2. Typical images of myoﬁbroblastoma
Fig. 3. Images from the operaPEN  ACCESS
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mesenchymal cell precursor and exhibit a spectrum of overlapping
histological and immunophenotypic properties, where differentia-
tion in myoﬁbroblastic direction, among others, is characterized
by positivity for antibodies against -smooth muscle actin and
desmin.4 Reported cases of myoﬁbroblastoma occurs most often in
women and men  aged 40–87 years.8 There is a tendency that myoﬁ-
broblastoma has a penchant for older men  and postmenopausal
women. There are no reported cases that indicate relation to gen-
der, race, medical conditions, use of medication or other effects of
growth factors. It is crucial to understand the molecular mecha-
nism, controlling growth and proliferation of myoﬁbroblasts. It is
believed that this mechanism is somewhat related to autocrine and
paracrine secretion of cytokines, which transform growth factors
in a particular way (TGF), but it is also demonstrated that spe-
ciﬁc tumor necrosis factor (TNF) and ﬁbroblastic peptide-trophic
growth factors are generally present in these tumors.3 Differential
diagnostic considerations include a number of mesenchymal/soft
tissue lesions and neoplasms, and ﬁbromatosis, which, unlike
myoﬁbroblastoma, is characterized by inﬁltrative growth and is
negative for CD34.9 Inﬂammatory myoﬁbrolastic tumor is charac-
terized by spindle shape myoﬁbroblastic cells with accompanying
inﬁltration of lymphocytes, plasma cells and histiocytes, which is
not found in this case.
 from mammography and ultrasound.
tion and the specimen.
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Fig. 4. HE, 20×. Well-deﬁned nodular tumor with “entrapped” islands of adipose
tissue.
Fig. 5. HE, 100×. Fascicular bundles of bipolar tumor cells with few collagen ﬁbers
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Fig. 6. ASM-Actin, 100×. Tumor cells with positive reaction, positive internal control
(smooth muscle cells in vascular wall).
Fig. 7. h-Caldesmon, 100×. Focal positivity in tumor cells.
nd  areas of adipose tissue.
The tumor is negative for S-100, which is typically positive at
chwannom and spindle cell lipoma. Morphology of tumor cells
nd immunohistochemical positivity for -smooth muscle actin,
esmin, vimentin and CD34 are in line with myoﬁbroblastic dif-
erentiation of the tumor. Whereas positivity for h-Caldesmon
uggest leiomyomatosis differentiation (Figs. 6–9).18 The malig-
ant variants of spindle cell presents typically greater cell density,
arked nuclear pleomorphism, high mitotic activity with atypical
itotic ﬁgures. It has been extensively debated whether solitary
brous tumor and myoﬁbroblastoma of the breast should be con-
idered as two distinct lesions. Indeed, there are some recent
eports considering these rare lesions as histologically different.11
yoﬁbroblastoma is most often described in women, who usually
resent with an asymptomatic and slowly enlarging breast tumor.
ammography typically shows a heterogeneous well-deﬁned
ncapsulated tumor without microcalciﬁcations. Ultrasonography
sually demonstrates a well demarcated tumor, although a vari-
ble and mixed echo pattern can be expected, sometimes with
ore distal acoustic attenuation as a result of incorporation of fat
issue and other types of tissue in tumor. Doppler modality may
how a slight peripheral hypervascularization of the tumor. Accord-
Fig. 8. CD34, 100×. Strong positive reaction in tumor cells, positive internal control
(endothelial  cells).
CASE  REPORT  –  O
96 M.  Mele et al. / International Journal of Su
i
ﬁ
r
m
d
c
h
t
4
a
t
a
t
f
C
FFig. 9. Desmin, 100×. Generally positive reaction in tumor cells.
ng to the imaging, the differential diagnosis includes hamartoma,
broadenoma and lipoma. Regarding the tumor size, most of the
eported cases dealt with lesions measuring from 1 to 3.7 cm of
aximum diameter. However, the tumor may  attain very large
imensions as present case and others recently published.1 We
oncur that Tru-cut biopsy is a reliable procedure in order to obtain
istological diagnosis before planning complete surgical excision of
he lesion.13–16
. Conclusion
Myoﬁbroblastoma is a well capsulated tumor with a good cleav-
ge plane, which usually allows easy surgical excision. Surgery is
he recommended treatment and, as long as the resection margins
re free, relapse is unlikely. Additionally, malignant transforma-
ion has not been reported yet. However, a minimum of 24 months’
ollow-up is desirable.
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